Shivan J Mehta1,2, Kevin G Volpp1,2, David A Asch1,2, Lee R Goldberg1, Louise B Russell1, Laurie A Norton1, Lauren G Iannotte1, Andrea B Troxel3. 1. Departments of Medicine and Health Policy and Medical Ethics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (S.J.M., K.G.V., D.A.A., L.R.G., L.B.R., L.A.N., L.G.I.). 2. The Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA (S.J.M., K.G.V., D.A.A.). 3. Division of Biostatistics, Department of Population Health, New York University School of Medicine, New York, NY (A.B.T.).
Abstract
BACKGROUND: Congestive heart failure is a major cause of morbidity, mortality, and cost. Disease management programs have shown promise but lack firm evidence of effectiveness and scalability. We describe the motivation, design, and planned analyses of EMPOWER (Electronic Monitoring of Patients Offers Ways to Enhance Recovery), a randomized clinical trial of an innovative intervention incorporating behavioral economic principles with remote monitoring technology embedded within a healthcare system. METHODS AND RESULTS: EMPOWER is an ongoing, pragmatic, randomized clinical trial comparing usual care to an automated hovering intervention that includes patient-level incentives for daily weight monitoring and diuretic adherence combined with automated feedback into the clinical care pathway, enabling real-time response to concerning clinical symptoms. Identification of eligible patients began in May 2016, and implementation of the intervention is feasible. Trial processes are embedded into existing clinical pathways. The primary outcome is time to readmission for any cause. Cost-effectiveness analyses are planned to evaluate the healthcare costs and health outcomes of the approach. CONCLUSIONS: The EMPOWER trial incorporates leading-edge approaches in human motivation, derived from behavioral economics, with contemporary technology to provide scale and exception handling at low cost. The trial is also implemented within the naturalized environment of a health system, as much as possible taking advantage of the existing journeys of patients and workflows of clinicians. A goal of this pragmatic design is to limit resource utilization and also to test an intervention that would need minimal modification to be translated from research into a new way of practice. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02708654.
RCT Entities:
BACKGROUND:Congestive heart failure is a major cause of morbidity, mortality, and cost. Disease management programs have shown promise but lack firm evidence of effectiveness and scalability. We describe the motivation, design, and planned analyses of EMPOWER (Electronic Monitoring of Patients Offers Ways to Enhance Recovery), a randomized clinical trial of an innovative intervention incorporating behavioral economic principles with remote monitoring technology embedded within a healthcare system. METHODS AND RESULTS: EMPOWER is an ongoing, pragmatic, randomized clinical trial comparing usual care to an automated hovering intervention that includes patient-level incentives for daily weight monitoring and diuretic adherence combined with automated feedback into the clinical care pathway, enabling real-time response to concerning clinical symptoms. Identification of eligible patients began in May 2016, and implementation of the intervention is feasible. Trial processes are embedded into existing clinical pathways. The primary outcome is time to readmission for any cause. Cost-effectiveness analyses are planned to evaluate the healthcare costs and health outcomes of the approach. CONCLUSIONS: The EMPOWER trial incorporates leading-edge approaches in human motivation, derived from behavioral economics, with contemporary technology to provide scale and exception handling at low cost. The trial is also implemented within the naturalized environment of a health system, as much as possible taking advantage of the existing journeys of patients and workflows of clinicians. A goal of this pragmatic design is to limit resource utilization and also to test an intervention that would need minimal modification to be translated from research into a new way of practice. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02708654.
Entities:
Keywords:
disease management; health care cost; heart failure; morbidity; mortality
Authors: Clara K Chow; Julie Redfern; Graham S Hillis; Jay Thakkar; Karla Santo; Maree L Hackett; Stephen Jan; Nicholas Graves; Laura de Keizer; Tony Barry; Severine Bompoint; Sandrine Stepien; Robyn Whittaker; Anthony Rodgers; Aravinda Thiagalingam Journal: JAMA Date: 2015 Sep 22-29 Impact factor: 56.272
Authors: Michael K Ong; Patrick S Romano; Sarah Edgington; Harriet U Aronow; Andrew D Auerbach; Jeanne T Black; Teresa De Marco; Jose J Escarce; Lorraine S Evangelista; Barbara Hanna; Theodore G Ganiats; Barry H Greenberg; Sheldon Greenfield; Sherrie H Kaplan; Asher Kimchi; Honghu Liu; Dawn Lombardo; Carol M Mangione; Bahman Sadeghi; Banafsheh Sadeghi; Majid Sarrafzadeh; Kathleen Tong; Gregg C Fonarow Journal: JAMA Intern Med Date: 2016-03 Impact factor: 21.873
Authors: Sarwat I Chaudhry; Jennifer A Mattera; Jeptha P Curtis; John A Spertus; Jeph Herrin; Zhenqiu Lin; Christopher O Phillips; Beth V Hodshon; Lawton S Cooper; Harlan M Krumholz Journal: N Engl J Med Date: 2010-11-16 Impact factor: 91.245
Authors: John G F Cleland; Amala A Louis; Alan S Rigby; Uwe Janssens; Aggie H M M Balk Journal: J Am Coll Cardiol Date: 2005-04-22 Impact factor: 24.094
Authors: Aditi P Sen; Taylor B Sewell; E Brooks Riley; Beth Stearman; Scarlett L Bellamy; Michelle F Hu; Yuanyuan Tao; Jingsan Zhu; James D Park; George Loewenstein; David A Asch; Kevin G Volpp Journal: J Gen Intern Med Date: 2014-02-13 Impact factor: 5.128
Authors: Kevin G Volpp; Leslie K John; Andrea B Troxel; Laurie Norton; Jennifer Fassbender; George Loewenstein Journal: JAMA Date: 2008-12-10 Impact factor: 56.272
Authors: Amber E Johnson; Shuvodra Routh; Christy N Taylor; Meagan Leopold; Kathryn Beatty; Dennis M McNamara; Esa M Davis Journal: JMIR Cardio Date: 2022-03-21
Authors: Virna Ribeiro Feitosa Cestari; Thiago Santos Garces; George Jó Bezerra Sousa; Thatiana Araújo Maranhão; João David Souza Neto; Maria Lúcia Duarte Pereira; Vera Lúcia Mendes de Paula Pessoa; João Tobias Lima Sales; Raquel Sampaio Florêncio; Lorena Campos de Souza; Glauber Gean de Vasconcelos; Maria Gyslane Vasconcelos Sobral; Lara Lídia Ventura Damasceno; Thereza Maria Magalhães Moreira Journal: Arq Bras Cardiol Date: 2022-01 Impact factor: 2.000
Authors: David A Asch; Andrea B Troxel; Lee R Goldberg; Monique S Tanna; Shivan J Mehta; Laurie A Norton; Jingsan Zhu; Lauren G Iannotte; Tamar Klaiman; Yuqing Lin; Louise B Russell; Kevin G Volpp Journal: JAMA Intern Med Date: 2022-06-01 Impact factor: 44.409